Volitionrx (VNRX) Net Cash Flow (QoQ) (2011 - 2025)
Volitionrx (VNRX) Net Cash Flow (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Volitionrx | 89,525.10 | -1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 132.15% |
| Sep 30, 2025 | -203.36% |
| Jun 30, 2025 | -5.80% |
| Mar 31, 2025 | 81.05% |
| Dec 31, 2024 | -4,320.01% |
| Sep 30, 2024 | 101.34% |
| Jun 30, 2024 | 31.42% |
| Mar 31, 2024 | -187.09% |
| Dec 31, 2023 | 210.52% |
| Sep 30, 2023 | -192.52% |
| Jun 30, 2023 | 1,313.57% |
| Mar 31, 2023 | 85.36% |
| Dec 31, 2022 | -1,205.53% |
| Sep 30, 2022 | 94.25% |
| Jun 30, 2022 | -324.88% |
| Mar 31, 2022 | 232.40% |
| Dec 31, 2021 | 50.89% |
| Sep 30, 2021 | 2.92% |
| Jun 30, 2021 | -137.75% |
| Mar 31, 2021 | 916.48% |